10,700 Shares in Astrana Health, Inc. $ASTH Acquired by Strs Ohio

Key Points

• Strs Ohio has acquired 10,700 shares of Astrana Health, Inc. for approximately $332,000, marking a new stake in the company during the first quarter.
• Astrana Health reported a net revenue of $654.81 million for its last quarter, exceeding analyst estimates, despite a loss of $0.17 per share against expectations.
• Six analysts have rated Astrana Health as a Buy, while the stock's average target price stands at $53.29, despite a recent downgrade from Zacks Research to a "strong sell" rating.

Strs Ohio purchased a new stake in shares of Astrana Health, Inc. (NASDAQ:ASTH - Free Report) during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 10,700 shares of the company's stock, valued at approximately $332,000.

A number of other institutional investors and hedge funds have also modified their holdings of the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in shares of Astrana Health by 3.9% during the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 24,505 shares of the company's stock worth $773,000 after buying an additional 915 shares during the period. US Bancorp DE grew its position in shares of Astrana Health by 21.3% in the first quarter. US Bancorp DE now owns 5,791 shares of the company's stock valued at $180,000 after purchasing an additional 1,015 shares during the last quarter. American Century Companies Inc. increased its stake in shares of Astrana Health by 1.9% in the first quarter. American Century Companies Inc. now owns 82,397 shares of the company's stock worth $2,555,000 after purchasing an additional 1,560 shares during the period. Covestor Ltd increased its stake in shares of Astrana Health by 777.6% in the first quarter. Covestor Ltd now owns 2,001 shares of the company's stock worth $62,000 after purchasing an additional 1,773 shares during the period. Finally, Linden Thomas Advisory Services LLC lifted its position in shares of Astrana Health by 11.9% during the 1st quarter. Linden Thomas Advisory Services LLC now owns 17,063 shares of the company's stock worth $529,000 after purchasing an additional 1,816 shares during the last quarter. 52.77% of the stock is currently owned by institutional investors and hedge funds.

Astrana Health Trading Up 2.1%

Shares of ASTH stock opened at $27.64 on Wednesday. The company has a market capitalization of $1.55 billion, a P/E ratio of 54.20, a P/E/G ratio of 0.67 and a beta of 0.85. Astrana Health, Inc. has a 12-month low of $21.20 and a 12-month high of $63.20. The company has a quick ratio of 1.59, a current ratio of 1.59 and a debt-to-equity ratio of 0.52. The firm has a 50-day moving average price of $27.50 and a 200 day moving average price of $27.95.

Astrana Health (NASDAQ:ASTH - Get Free Report) last posted its quarterly earnings data on Thursday, August 7th. The company reported $0.19 earnings per share for the quarter, missing the consensus estimate of $0.36 by ($0.17). Astrana Health had a return on equity of 3.43% and a net margin of 1.04%.The firm had revenue of $654.81 million for the quarter, compared to analyst estimates of $639.13 million. During the same period in the previous year, the business posted $0.40 EPS. The business's quarterly revenue was up 34.7% on a year-over-year basis. Astrana Health has set its Q3 2025 guidance at EPS. Research analysts forecast that Astrana Health, Inc. will post 1.15 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Separately, Zacks Research lowered Astrana Health from a "strong-buy" rating to a "strong sell" rating in a report on Monday, September 1st. Six equities research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $53.29.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.

Want to see what other hedge funds are holding ASTH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astrana Health, Inc. (NASDAQ:ASTH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.